Similarly, increased IL‐17A and IFN‐γ levels were presented in the symptomatic AL group on POD 3 and 5 (P = .037 and P = .005, respectively), (P = .009 and P = .005, respectively). The gene discussed is IL17A; the disease is axial length measurement.